|
|
|
|
Active Indication- |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismVEGFR2 antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Fusion Biotech Co. Ltd.
0 Patents (Medical) associated with Fusion Biotech Co. Ltd.
100 Deals associated with Fusion Biotech Co. Ltd.
100 Translational Medicine associated with Fusion Biotech Co. Ltd.